PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 137 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2014. The put-call ratio across all filers is 1.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,071,000 | -64.8% | 285,091 | -54.5% | 1.41% | -1.9% |
| Q2 2018 | $37,084,000 | +29.1% | 626,950 | +48.6% | 1.43% | +25.9% |
| Q1 2018 | $28,715,000 | +228.5% | 421,966 | +322.0% | 1.14% | +578.0% |
| Q2 2017 | $8,740,000 | -48.5% | 100,000 | -78.1% | 0.17% | -61.6% |
| Q1 2017 | $16,967,000 | +23.2% | 456,097 | +1.7% | 0.44% | +64.9% |
| Q4 2016 | $13,768,000 | -21.3% | 448,471 | -23.6% | 0.26% | -24.3% |
| Q2 2016 | $17,490,000 | +319.8% | 587,126 | +1367.8% | 0.35% | +79.5% |
| Q1 2014 | $4,166,000 | – | 40,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |